Multiple Sclerosis Banner

Featured Article

Exploring the Benefits of Virtual Reality Rehabilitation in Multiple Sclerosis

Exploring the Benefits of Virtual Reality Rehabilitation in Multiple Sclerosis

Future studies on VR training for MS should include large randomized controlled trials using clear protocols and comparable between-group tasks.

Latest

A New Look at Demyelination and White Matter Density in Multiple Sclerosis

A New Look at Demyelination and White Matter Density in Multiple Sclerosis

Investigators propose that myelocortical multiple sclerosis may be a subtype of multiple sclerosis.

Cannabinoids Mildly Effective for Treating MS Symptoms in Adults

Cannabinoids Mildly Effective for Treating MS Symptoms in Adults

Cannabinoids may be mildly effective at treating spasticity, pain, and bladder dysfunction in adults with multiple sclerosis.

Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis

Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis

Investigators examine the role of physical activity and exercise in the modification of vascular comorbidities and risk factors in individuals with multiple sclerosis.

DMTs Do Not Moderate Disability in Patients With MS and Diabetes, Other Comorbidities

DMTs Do Not Moderate Disability in Patients With MS and Diabetes, Other Comorbidities

All participants were smokers or had either diabetes, cancer, depression, cardiovascular, respiratory, thyroid, or gastrointestinal disease and were receiving a DMT.

Glatiramer Acetate Associated With Long-Term Disability Improvements in MS

Glatiramer Acetate Associated With Long-Term Disability Improvements in MS

Natural history data from a subset of patients from the British Columbia MS database between 1980 to 1996 were used to create a continuous Markov model to model the projected course of disease in untreated people with RMS.

Fingolimod Compared With Glatiramer Acetate in Head-to-Head MS Study

Fingolimod Compared With Glatiramer Acetate in Head-to-Head MS Study

Compared with Copaxone injection, treatment with oral Gilenya significantly reduced the annualized relapse rate in patients with relapsing remitting multiple sclerosis.

Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis

Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis

Researchers categorized samples into quintiles based on 25(OH)D3 concentrations in healthy controls.

High-Dose Biotin May Be an Effective Treatment for Progressive MS

High-Dose Biotin May Be an Effective Treatment for Progressive MS

Patients with progressive MS or secondary progressive MS who were receiving care at a single institution in France were prescribed 300 mg/day MD1003.

Lower Relapse Risk and Disability Progression With Oral DMT in Treatment-Naive RRMS

Lower Relapse Risk and Disability Progression With Oral DMT in Treatment-Naive RRMS

In patients with relapse-remitting multiple sclerosis, the initiation of oral disease-modifying therapies is associated with a lower relapse risk as well as a lower risk for disability progression.

MS Relapse Rates After DMT Initiation Similar Between Pediatric-, Adult-Onset MS

MS Relapse Rates After DMT Initiation Similar Between Pediatric-, Adult-Onset MS

Disability progression is slower among patients with pediatric-onset multiple sclerosis.

Sign Up for Free e-newsletters



CME Focus